MCF7 Human Breast Cancer Cells Engineered to Stably Overexpress DEPTOR via CRISPR/Cas9 to Reduce Anabolic Capacity

J. William Deaver(Texas A&M University), James D. Fluckey(Texas A&M University), Steven E. Riechman, Melinda Sheffield‐Moore, Peter P. Nghiem(Texas A&M University), Sara Mata López(Texas A&M University)
The FASEB Journal
April 1, 2020
Cited by 0


Related Papers